Theratechnologies (NASDAQ:THTX) Issues Earnings Results

Theratechnologies (NASDAQ:THTX) announced its quarterly earnings results on Thursday. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.03, Yahoo Finance reports. During the same quarter last year, the firm earned ($0.03) earnings per share. Theratechnologies updated its FY 2024 guidance to EPS.

Theratechnologies Trading Up 3.7 %

Shares of THTX opened at $1.26 on Friday. The stock’s 50-day moving average price is $1.28 and its two-hundred day moving average price is $1.34. Theratechnologies has a 12 month low of $0.88 and a 12 month high of $2.58. The company has a market capitalization of $58.16 million, a PE ratio of -6.66 and a beta of 1.41.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.